Scancell Holdings PLC SCLP.L

GBX22.83 GBX1.75 (8.30%) 1D

Last Updated: May 15, 12:00 AM·LSE

SCLP.L Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 11, 2025

Report Source: 2025 Annual Report

Scancell Holdings PLC

Scancell Holdings PLC. Stock Analysis SCLP.L

United Kingdom Health Care Micro Cap Report:
Scancell Holdings Plc is a clinical stage biotechnology company, which develops targeted off-the-shelf active immunotherapies. The firm is engaged in studying the human adaptive immune system, to generate medicines to treat unmet needs in cancer. The firm is building a pipeline of products by utilizing its four technology platforms: Moditope and ImmunoBody for vaccines and GlyMab and AvidiMab for antibodies. Its product pipeline includes Modi-1, Modi-2, SCIB1 & iSCIB1+, SCIB2, SC129, SC134, SC2811, SC27, and others. Modi-1 is the first therapeutic vaccine candidate from the Company’s Moditope platform, which targets citrullinated peptides from two different proteins which have been combined to reduce the possibility of tumor escape and have each been conjugated to a toll-like receptor (TLR) 1/2 agonist, which acts as an adjuvant. Modi-2, which targets homocitrullinated cancer antigens, is the second therapeutic vaccine candidate from the Company’s Moditope platform and has the potential to address different cancer indications to Modi-1.
Read More

Scancell Holdings PLC (SCLP.L) Chart

Key Statistics of Scancell Holdings PLC (SCLP.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX22.00GBX22.50

Today's Open

GBX21.08

Volume

11.23K

P/E Ratio (TTM)

-

52 Week Range

GBX8.10GBX22.90

Market Cap

15.67B

Avg. Volume

679.73K

Dividend Yield

-

Financial Metrics & Statements of Scancell Holdings PLC (SCLP.L)

FAQ's for Scancell Holdings PLC (SCLP.L)

  • According to Musaffa’s Shariah screening methodology, Scancell Holdings PLC (SCLP.L) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.